Lincoln Pharmaceuticals Proposes Rs 1.80 Final Dividend for FY26
Lincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.
Read article